Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma

Background Esophageal cancer is a very common malignant tumor in China, especially esophageal squamous cell carcinoma (ESCC), but there is currently no effective treatment for patients after first-line chemotherapy failure. Apatinib has shown promising outcomes in treatment with various solid tumors...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Invest New Drugs
Main Authors: Zhao, Jian, Lei, Junmei, Yu, Junyan, Zhang, Chengyan, Song, Xuefeng, Zhang, Ninggang, Wang, Yusheng, Zhang, Suxiang
Format: Artigo
Jezik:Inglês
Izdano: Springer US 2019
Teme:
Phase II Studies
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7066276/
https://ncbi.nlm.nih.gov/pubmed/31650447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-019-00866-5
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki